CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential

Clinical and Experimental Metastasis

Volumn 27, Issue 7, 2010, Pages 517-527

  Li, Guangqiu ^a   Liu, Chao ^a   Yuan, Jian ^a   Xiao, Xiaoqin ^a   Tang, Na ^a   Hao, Junmei ^a   Wang, Hongwei ^a   Bian, Xiuwu ^b   Deng, Yongjian ^a   Ding, Yanqing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD133; Colorectal cancer; Heterogeneity; Metastasis; Single cell derived progenies

Indexed keywords

CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HERMES ANTIGEN; PROMININ 1; TUMOR MARKER; UNCLASSIFIED DRUG; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LIVER METASTASIS; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; ORTHOTOPIC TRANSPLANTATION; XENOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL TUMOR; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METASTASIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA PRIMERS; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77957374304     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9341-0     Document Type: Article

References (44)

1. H Nelson N Petrelli A Carlin, et al. 2001 Guidelines 2000 for colon and rectal cancer surgery J Natl Cancer Inst 93 8 583 596 1:STN:280: DC%2BD3M3hvFejtg%3D%3D 10.1093/jnci/93.8.583 11309435
2. JB O'Connell MA Maggard CY Ko 2004 Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 19 1420 1425 10.1093/jnci/djh275 15467030 (Pubitemid 39429665)
3. SJ Miller RM Lavker TT Sun 2005 Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications Biochim Biophys Acta 1756 1 25 52 1:CAS:528:DC%2BD2MXhtVensbjL 16139432
4. M Al-Hajj MW Becker M Wicha, et al. 2004 Therapeutic implications of cancer stem cells Curr Opin Genet Dev 14 1 43 47 1:CAS:528: DC%2BD2cXps1yltQ%3D%3D 10.1016/j.gde.2003.11.007 15108804 (Pubitemid 38167476)
5. T Brabletz A Jung S Spaderna, et al. 2005 Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression Nat Rev Cancer 5 9 744 749 1:CAS:528:DC%2BD2MXpsleksLw%3D 10.1038/nrc1694 16148886 (Pubitemid 41486367)
6. CA O'Brien A Pollett S Gallinger, et al. 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 7123 106 110 10.1038/nature05372 17122772 (Pubitemid 46067310)
7. L Ricci-Vitiani DG Lombardi E Pilozzi, et al. 2007 Identification and expansion of human colon-cancer-initiating cells Nature 445 7123 111 115 1:CAS:528:DC%2BD2sXhsFOmug%3D%3D 10.1038/nature05384 17122771 (Pubitemid 46067311)
8. P Dalerba SJ Dylla IK Park, et al. 2007 Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci USA 104 24 10158 10163 1:CAS:528:DC%2BD2sXmvVCntLw%3D 10.1073/pnas.0703478104 17548814 (Pubitemid 47175279)
9. + cells is associated with poor prognosis in colon carcinoma patients with stage IIIB J Transl Med 7 56 1:CAS:528:DC%2BD1MXos1ymt70%3D 10.1186/1479-5876-7-56 19583834
10. D Choi HW Lee KY Hur, et al. 2009 Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma World J Gastroenterol 15 18 2258 2264 1:CAS:528:DC%2BD1MXpsF2rs7s%3D 10.3748/wjg.15.2258 19437567
11. D Horst SK Scheel S Liebmann, et al. 2009 The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer J Pathol 219 4 427 434 1:CAS:528: DC%2BC3cXjsVKrsQ%3D%3D 10.1002/path.2597 19621338
12. Q Wang ZG Chen CZ Du, et al. 2009 Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer Histopathology 55 3 284 293 10.1111/j.1365-2559.2009.03378.x 19723143
13. D Horst L Kriegl J Engel, et al. 2008 CD133 expression is an independent prognostic marker for low survival in colorectal cancer Br J Cancer 99 8 1285 1289 1:CAS:528:DC%2BD1cXht1Cmtr%2FP 10.1038/sj.bjc.6604664 18781171
14. D Horst L Kriegl J Engel, et al. 2009 Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer Cancer Invest 27 8 844 850 10.1080/07357900902744502 19626493
15. K Polyak RA Weinberg 2009 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 4 265 273 1:CAS:528:DC%2BD1MXis1Chtb0%3D 10.1038/nrc2620 19262571
16. SA Mani W Guo MJ Liao, et al. 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 4 704 715 1:CAS:528:DC%2BD1cXmsVOru7w%3D 10.1016/j.cell.2008.03.027 18485877 (Pubitemid 351636299)
17. H Hugo ML Ackland T Blick, et al. 2007 Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression J Cell Physiol 213 2 374 383 1:CAS:528:DC%2BD2sXhtFKnu7rE 10.1002/jcp.21223 17680632 (Pubitemid 47509716)
18. T Joyce D Cantarella C Isella, et al. 2009 A molecular signature for epithelial to mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis Clin Exp Metastasis 26 6 569 587 1:CAS:528:DC%2BD1MXptFClsL0%3D 10.1007/s10585-009-9256-9 19340593
19. SK Singh ID Clarke M Terasaki, et al. 2003 Identification of a cancer stem cell in human brain tumors Cancer Res 63 18 5821 5828 1:CAS:528: DC%2BD3sXnvVSjtbc%3D 14522905
20. SK Singh C Hawkins ID Clarke, et al. 2004 Identification of human brain tumour initiating cells Nature 432 7015 396 401 1:CAS:528:DC%2BD2cXpvVCjtbY%3D 10.1038/nature03128 15549107 (Pubitemid 39551674)
21. AT Collins PA Berry C Hyde, et al. 2005 Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 23 10946 10951 1:CAS:528:DC%2BD2MXht1KjsrzP 10.1158/0008-5472.CAN-05-2018 16322242 (Pubitemid 41713363)
22. DJ Vander Griend WL Karthaus S Dalrymple, et al. 2008 The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells Cancer Res 68 23 9703 9711 1:CAS:528:DC%2BD1cXhsVegtbvI 10.1158/0008-5472.CAN-08-3084 19047148
23. S Yin J Li C Hu, et al. 2007 CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity Int J Cancer 120 7 1444 1450 1:CAS:528:DC%2BD2sXis12is7k%3D 10.1002/ijc.22476 17205516 (Pubitemid 46355378)
24. PC Hermann SL Huber T Herrler, et al. 2007 Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 3 313 323 1:CAS:528:DC%2BD2sXhtFagu7vN 10.1016/j.stem.2007.06.002 18371365 (Pubitemid 47355323)
25. A Eramo F Lotti G Sette, et al. 2008 Identification and expansion of the tumorigenic lung cancer stem cell population Cell Death Differ 15 3 504 514 1:CAS:528:DC%2BD1cXitVOlsLo%3D 10.1038/sj.cdd.4402283 18049477 (Pubitemid 351267301)
26. CV Cox P Diamanti RS Evely, et al. 2009 Expression of CD133 on leukemia-initiating cells in childhood ALL Blood 113 14 3287 3296 1:CAS:528:DC%2BD1MXksFWqsbY%3D 10.1182/blood-2008-04-154187 19147788
27. G Rappa O Fodstad A Lorico 2008 The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma Stem Cells 26 12 3008 3017 1:CAS:528:DC%2BD1MXhtFSktrg%3D 10.1634/stemcells.2008-0601 18802032
28. - metastatic colon cancer cells initiate tumors J Clin Invest 118 6 2111 2120 1:CAS:528:DC%2BD1cXntVCmtLk%3D 18497886
29. MA LaBarge MJ Bissell 2008 Is CD133 a marker of metastatic colon cancer stem cells? J Clin Invest 118 6 2021 2024 1:CAS:528:DC%2BD1cXntVCmtrc%3D 18497883
30. L Liu Q Zhang Y Zhang, et al. 2006 Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line Neoplasia 8 11 917 924 1:CAS:528:DC%2BD28Xht1eitrfJ 10.1593/neo.06364 17132223 (Pubitemid 44706241)
31. E Quintana M Shackleton MS Sabel, et al. 2008 Efficient tumour formation by single human melanoma cells Nature 456 7222 593 598 1:CAS:528: DC%2BD1cXhsVGlur7K 10.1038/nature07567 19052619
32. JM Hao JZ Chen HM Sui, et al. 2010 A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer J Pathol 220 4 475 489 1:CAS:528:DC%2BC3cXjsFentL8%3D 20077526
33. + population efficiently enriches colon cancer initiating cells Ann Surg Oncol 15 10 2927 2933 10.1245/s10434-008-0074-0 18663533
34. T Reya SJ Morrison MF Clarke, et al. 2001 Stem cells, cancer, and cancer stem cells Nature 414 6859 105 111 1:CAS:528:DC%2BD3MXot1ahs7c%3D 10.1038/35102167 11689955 (Pubitemid 33041634)
35. Snippert HJ, van Es JH, van den Born M, et al (2009) Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 136(7):2187-2194 e1
36. S Yoshikawa Y Zen T Fujii, et al. 2009 Characterization of CD133+ parenchymal cells in the liver: histology and culture World J Gastroenterol 15 39 4896 4906 1:CAS:528:DC%2BD1MXhtlCiu7zP 10.3748/wjg.15.4896 19842219
37. D Beier P Hau M Proescholdt, et al. 2007 CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles Cancer Res 67 9 4010 4015 1:CAS:528:DC%2BD2sXltVyku74%3D 10.1158/0008-5472.CAN-06-4180 17483311 (Pubitemid 46815044)
38. - glioblastoma-derived cancer stem cell lines suggest different cells of origin Cancer Res 70 5 2030 2040 1:CAS:528:DC%2BC3cXisFWis74%3D 10.1158/0008-5472.CAN-09-1707 20145155
39. - subpopulations of A549 and H446 cells contain cancer-initiating cells Cancer Sci 100 6 1040 1046 1:CAS:528:DC%2BD1MXntlSjtL4%3D 10.1111/j.1349-7006.2009.01144.x 19385971
40. S Pece D Tosoni S Confalonieri, et al. 2010 Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content Cell 140 1 62 73 1:CAS:528:DC%2BC3cXkvVWiur0%3D 10.1016/j.cell.2009.12.007 20074520
41. N Barker JH van Es J Kuipers, et al. 2007 Identification of stem cells in small intestine and colon by marker gene Lgr5 Nature 449 7165 1003 1007 1:CAS:528:DC%2BD2sXht1Wgtr3E 10.1038/nature06196 17934449 (Pubitemid 350014593)
42. T Sato RG Vries HJ Snippert, et al. 2009 Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche Nature 459 7244 262 265 1:CAS:528:DC%2BD1MXjslartrg%3D 10.1038/nature07935 19329995
43. L Zhu P Gibson DS Currle, et al. 2009 Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation Nature 457 7229 603 607 1:CAS:528:DC%2BD1MXhtFOmsbs%3D 10.1038/nature07589 19092805
44. M Morimoto-Tomita Y Ohashi A Matsubara, et al. 2005 Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth Clin Exp Metastasis 22 6 513 521 10.1007/s10585-005-3585-0 16320114 (Pubitemid 41750703)